These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8127076)

  • 21. [Enzyme deficiencies detected on cultured fibroblasts and amniotic cells. Application to prenatal diagnosis].
    Dreyfus JC; Poenaru L
    Ann Biol Clin (Paris); 1975; 33(6):465-72. PubMed ID: 818927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy.
    Meikle PJ; Ranieri E; Simonsen H; Rozaklis T; Ramsay SL; Whitfield PD; Fuller M; Christensen E; Skovby F; Hopwood JJ
    Pediatrics; 2004 Oct; 114(4):909-16. PubMed ID: 15466084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of Lysosomal storage disorders at a medical genetics center in northern India.
    Verma PK; Ranganath P; Dalal AB; Phadke SR
    Indian Pediatr; 2012 Oct; 49(10):799-804. PubMed ID: 22791670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligosaccharide analysis in urine by maldi-tof mass spectrometry for the diagnosis of lysosomal storage diseases.
    Xia B; Asif G; Arthur L; Pervaiz MA; Li X; Liu R; Cummings RD; He M
    Clin Chem; 2013 Sep; 59(9):1357-68. PubMed ID: 23676310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study on enzyme activities of some sphingolipidoses.
    Ozkara HA; Arikan MC; Topçu M; Emre S; Renda Y
    Turk J Pediatr; 1994; 36(3):215-21. PubMed ID: 7974812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylamine accumulation in cultured cells as a measure of the aqueous storage compartment in the laboratory diagnosis of genetic lysosomal diseases.
    Kopitz J; Harzer K; Kohlschütter A; Zöller B; Blenck N; Cantz M
    Am J Med Genet; 1996 May; 63(1):198-202. PubMed ID: 8723110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prenatal diagnosis of lysosomal diseases].
    Owada M; Nishiya O; Moriya M
    Nihon Rinsho; 1995 Dec; 53(12):2926-32. PubMed ID: 8577037
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of patients with lysosomal storage disorders and peroxisomal disorders: A nationwide survey in Japan.
    Koto Y; Sakai N; Lee Y; Kakee N; Matsuda J; Tsuboi K; Shimozawa N; Okuyama T; Nakamura K; Narita A; Kobayashi H; Uehara R; Nakamura Y; Kato K; Eto Y
    Mol Genet Metab; 2021 Jul; 133(3):277-288. PubMed ID: 34090759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of amniotic fluid chitotriosidase in the prenatal diagnosis of lysosomal storage disorders.
    Kadali S; Madalasa T; Reddy GM; Naushad SM
    Clin Biochem; 2018 Nov; 61():40-44. PubMed ID: 30205089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prenatal diagnosis of lysosomal storage disease in the USSR].
    Mirenburg TV; Aronovich EL; Krasnopol'skaia KD; Lebedeva TV; Akhunov VS; Biriukov VB; Bakharev VA; Bartseva OB
    Akush Ginekol (Mosk); 1991 Mar; (3):12-8. PubMed ID: 1905498
    [No Abstract]   [Full Text] [Related]  

  • 31. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
    Inui K; Wenger DA
    J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fast protocol for the diagnosis of lysosomal diseases in nonimmune hydrops fetalis.
    Gort L; Granell MR; Fernández G; Carreto P; Sanchez A; Coll MJ
    Prenat Diagn; 2012 Dec; 32(12):1139-42. PubMed ID: 22991067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis).
    Piraud M; Froissart R; Mandon G; Bernard A; Maire I
    Clin Chim Acta; 1996 Apr; 248(2):143-55. PubMed ID: 8740579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene Therapy of Sphingolipid Metabolic Disorders.
    Shaimardanova AA; Solovyeva VV; Issa SS; Rizvanov AA
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening methods for the diagnosis of lysosomal storage disease].
    Mutoh T; Kuriyama M
    Nihon Rinsho; 1995 Dec; 53(12):2933-7. PubMed ID: 8577038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antenatal diagnosis of sphingolipid and mucopolysaccharide storage diseases.
    Lowden JA; Rudd N; Cutz E; Doran TA
    Can Med Assoc J; 1975 Sep; 113(6):507-11. PubMed ID: 808260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.
    Piraud M; Pettazzoni M; Lavoie P; Ruet S; Pagan C; Cheillan D; Latour P; Vianey-Saban C; Auray-Blais C; Froissart R
    J Inherit Metab Dis; 2018 May; 41(3):457-477. PubMed ID: 29556840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal enzymatic diagnosis of lysosomal storage diseases using cultured amniotic cells, uncultured chorionic villus samples, and fetal blood cells: Hacettepe experience.
    Unal C; Ozkara HA; Tanacan A; Fadiloglu E; Lay I; Topçu M; Cakar AN; Beksac MS
    Prenat Diagn; 2019 Nov; 39(12):1080-1085. PubMed ID: 31411753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of urinary oligosaccharide excretion patterns by UHPLC/HRAM mass spectrometry for screening of lysosomal storage disorders.
    Hagemeijer MC; van den Bosch JC; Bongaerts M; Jacobs EH; van den Hout JMP; Oussoren E; Ruijter GJG
    J Inherit Metab Dis; 2023 Mar; 46(2):206-219. PubMed ID: 36752951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability of acid hydrolase activities in cultured skin fibroblasts and amniotic fluid cells.
    Young E; Willcox P; Whitfield AE; Patrick AD
    J Med Genet; 1975 Sep; 12(3):224-9. PubMed ID: 809585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.